Long-Term Safety and Efficacy of Hyper-CVAD Plus Ponatinib As Frontline Therapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Nicholas J. Short, Elias Jabbour, Farhad Ravandi et al.|Blood|2019

Cited by 39